Share This Link

Asthma: Asthma is not a specific contraindication or condition requiring special precaution when administering imipenem. Although any medication has the potential to cause hypersensitivity reactions, including bronchospasm in susceptible individuals, asthma itself does not significantly increase the risk of the serious adverse effects associated with imipenem. The nurse should instead assess for a history of allergies to beta-lactam antibiotics, such as penicillins, cephalosporins, or other carbapenems, because cross-sensitivity may occur.

Diabetes mellitus: Diabetes mellitus does not directly increase the risk of toxicity or serious adverse reactions associated with imipenem therapy. While infections are more common and may be more severe in diabetic patients due to impaired immune function, the presence of diabetes alone does not warrant additional precautions specific to this medication. Routine monitoring of blood glucose and infection response should continue, but diabetes is not the primary concern when administering imipenem.

Hypertension: Hypertension is not a recognized contraindication or major precaution associated with imipenem therapy. Although blood pressure should be routinely monitored as part of comprehensive patient assessment, imipenem does not typically produce clinically significant hypertensive or hypotensive effects. Nursing priorities during imipenem therapy focus primarily on identifying allergic reactions, monitoring renal function, assessing for superinfection, and recognizing neurological complications such as seizures.

Administer the medication with food: Administering cephalexin with food may reduce gastrointestinal adverse effects such as nausea, abdominal discomfort, or gastric irritation, but it does not reduce the risk of an allergic or anaphylactic reaction. A history of penicillin-induced anaphylaxis represents a significant safety concern that must be addressed before the medication is administered. Preventing a potentially life-threatening hypersensitivity reaction takes priority over minimizing gastrointestinal side effects.

Give the medication at a slower rate: Slowing the rate of administration does not prevent an IgE-mediated hypersensitivity reaction or decrease the likelihood of anaphylaxis. Allergic reactions occur because of immune system recognition of the drug rather than the speed at which it is administered. If cephalexin is contraindicated due to a history of severe penicillin allergy, administering it more slowly still places the client at risk for bronchospasm, angioedema, hypotension, and cardiovascular collapse.

Monitor temperature: Monitoring the client's temperature is appropriate for evaluating the effectiveness of antibiotic therapy and identifying persistent or worsening infection. However, temperature assessment does not address the immediate safety concern associated with administering a cephalosporin to a client with a documented history of penicillin-induced anaphylaxis. The allergy must be clarified and the provider notified before the medication is given, making temperature monitoring a lower-priority intervention.

Stat: "Stat" is derived from the Latin word statim, meaning immediately. A medication prescribed as stat requires prompt administration because the patient's condition necessitates urgent therapeutic intervention, such as during cardiac arrest, severe allergic reactions, or status epilepticus. This abbreviation does not indicate that the medication is administered only when symptoms occur, making it different from PRN.

Daily: A medication ordered daily is administered once every day at approximately the same time to maintain a consistent therapeutic drug concentration in the bloodstream. This type of order is scheduled and is independent of the patient's symptoms or immediate clinical condition. Therefore, "daily" does not correspond to the meaning of PRN, which requires administration based on the patient's need.

Every other day: "Every other day" refers to a medication schedule in which the drug is administered on alternate days, typically every 48 hours. This is a fixed dosing regimen designed to maintain therapeutic effectiveness while minimizing toxicity for certain medications. It is unrelated to PRN administration because it follows a predetermined schedule rather than being based on the patient's symptoms or clinical needs.

"Take this medication on an empty stomach for best absorption.": Interferon alfa-2b is administered by subcutaneous or intramuscular injection rather than orally, making food intake irrelevant to its absorption. Instead of focusing on meals, nursing education should emphasize proper injection technique, rotating injection sites, appropriate storage of the medication, and management of common adverse effects such as flu-like symptoms.

"This medication may cause a dry mouth.": Although some clients may experience dry mouth during therapy, it is not one of the most significant or life-threatening adverse effects associated with interferon alfa-2b. More clinically important complications include severe depression, suicidal ideation, bone marrow suppression, hepatotoxicity, thyroid dysfunction, and increased susceptibility to infection. Nursing education should prioritize adverse effects that require immediate recognition and intervention rather than relatively minor discomforts.

"This medication may cause your urine to turn orange.": Orange discoloration of urine is not an expected adverse effect of interferon alfa-2b. Urine discoloration is more commonly associated with medications such as phenazopyridine, rifampin, or certain vitamin supplements. Providing inaccurate medication information may confuse the client and distract from recognizing serious adverse reactions that require prompt medical evaluation.

A healthy 20-year-old college student: A healthy young adult without chronic medical conditions or immunocompromising disorders is not routinely recommended to receive pneumococcal vaccination. Although college students are encouraged to receive certain vaccines, such as meningococcal and annual influenza vaccines because of close living environments, pneumococcal vaccination is generally reserved for individuals with specific risk factors. This client does not meet the primary indications for routine pneumococcal immunization.

A pregnant client in the first trimester: Pregnancy alone is not a routine indication for pneumococcal vaccination in otherwise healthy women. Although pneumococcal vaccination may be considered during pregnancy for women with certain high-risk conditions, such as immunodeficiency, chronic heart disease, chronic lung disease, or functional asplenia, it is not routinely administered solely because a client is pregnant. Consequently, this client is not the primary recipient of the pneumococcal vaccine in the absence of additional risk factors.

A child with eczema: Eczema (atopic dermatitis) is a chronic inflammatory skin disorder and, by itself, does not increase the risk of invasive pneumococcal disease or constitute an indication for pneumococcal vaccination beyond the routine childhood immunization schedule. Children receive pneumococcal conjugate vaccines according to the standard pediatric vaccination schedule regardless of whether they have eczema. Therefore, eczema alone does not make this child a priority candidate compared with an older adult with chronic pulmonary disease.

Oral medications require less monitoring compared to intravenous medications: Although many oral medications are relatively safe, the degree of monitoring depends on the medication being administered and the patient's clinical condition rather than the route alone. Numerous oral medications, such as anticoagulants, insulin, opioids, and chemotherapy agents, require intensive monitoring for therapeutic effectiveness and toxicity. Therefore, it is inaccurate to state that oral medications universally require less monitoring than intravenous medications.

Intravenous medications are absorbed in the stomach faster than oral ones: Intravenous medications are not absorbed through the stomach or gastrointestinal tract because they are administered directly into the venous circulation. This route bypasses the processes of gastrointestinal absorption and first-pass hepatic metabolism, allowing the medication to reach systemic circulation immediately. Consequently, IV medications produce a much faster therapeutic effect than oral medications.

Oral medications have fewer side effects compared to intravenous medications: The occurrence of side effects depends primarily on the pharmacological properties of the medication, dosage, patient-specific factors, and duration of therapy rather than the route of administration alone. Oral medications may cause gastrointestinal irritation, hepatotoxicity, allergic reactions, or systemic adverse effects, while intravenous medications carry additional risks such as infiltration, phlebitis, extravasation, and bloodstream infections. Therefore, neither route can be universally described as having fewer side effects than the other.

Administer the medication with food: Some broad-spectrum antibiotics may be administered with food to reduce gastrointestinal irritation, nausea, or abdominal discomfort, while others should be taken on an empty stomach to maximize absorption. Therefore, administration with food depends on the specific antibiotic rather than the presence of renal impairment. Although minimizing gastrointestinal side effects is beneficial, it is not the primary nursing priority when caring for a client with compromised renal function.

Increase the dosage to ensure effectiveness: Increasing the antibiotic dose in a client with renal impairment is potentially dangerous because impaired renal clearance allows the drug to remain in the circulation for a longer period. Higher doses can lead to toxic serum concentrations without improving antimicrobial efficacy and may significantly increase the risk of irreversible kidney injury or neurological complications. Dosage adjustments for renal impairment generally involve reducing the dose or extending the dosing interval.

Administer the medication via the oral route: The route of antibiotic administration is determined by factors such as the severity of the infection, the client's clinical condition, gastrointestinal function, and the pharmacokinetic properties of the medication rather than renal function alone. Clients with severe infections may require intravenous therapy regardless of kidney function to achieve rapid therapeutic concentrations. Therefore, selecting the oral route is not the priority consideration.

Restrict fluid intake during therapy: Fluid restriction is not recommended during mebendazole therapy because the medication does not significantly affect fluid balance or renal function. Children should continue to maintain adequate hydration to support normal physiological function and overall health throughout treatment. Preventing reinfection depends primarily on appropriate medication administration and meticulous hygiene practices rather than alterations in fluid intake.

Take the medication on an empty stomach: Mebendazole may be administered with or without food because food does not significantly reduce its therapeutic effectiveness in the treatment of pinworm infections. Although administration with a fatty meal may increase systemic absorption, this is generally unnecessary since the medication exerts its primary effect locally within the intestinal lumen. Therefore, taking the medication on an empty stomach is not a routine recommendation and does not contribute to preventing reinfection.

Isolate the child during treatment: Isolation of the child is not necessary because pinworm infection is managed through pharmacological treatment and rigorous infection-control measures rather than patient isolation. Preventive strategies include frequent handwashing, keeping fingernails short and clean, daily bathing, changing underwear each day, and washing bedding, towels, and clothing in hot water to remove eggs. In many cases, treatment of all household members is also recommended because asymptomatic family members frequently harbor the infection and can contribute to reinfection.

To evaluate if the medication is causing anemia: Although prolonged antibiotic therapy may occasionally be associated with hematologic abnormalities such as neutropenia or thrombocytopenia, anemia is not the primary reason for monitoring vancomycin trough levels. Evaluation of anemia is performed through laboratory studies such as a complete blood count (CBC) rather than serum drug concentration measurements. Therefore, obtaining a trough level does not assess whether vancomycin is causing anemia.

To assess whether the medication is affecting liver function: Vancomycin is eliminated predominantly through renal excretion and has minimal hepatic metabolism. Consequently, liver function tests are not routinely monitored to guide vancomycin dosing or evaluate therapeutic effectiveness. The primary concern during vancomycin therapy is nephrotoxicity, making renal function tests such as serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and serum trough concentrations more clinically relevant than liver function studies.

To determine if the client has developed antibiotic resistance: Antibiotic resistance is determined through microbiological testing, including bacterial culture and antimicrobial susceptibility testing, rather than by measuring serum vancomycin concentrations. A therapeutic trough level indicates that adequate drug concentrations are present in the bloodstream but does not provide information regarding the susceptibility of the infecting organism. Vancomycin trough monitoring cannot determine bacterial resistance development.